Anthony Schwarer

Professor

19952019
If you made any changes in Pure these will be visible here soon.

Research Output 1995 2019

Filter
Letter
2018
2 Citations (Scopus)

Adaptive reprogramming of NK cells in X-Linked lymphoproliferative syndrome

Opat, S., Hearps, A. C., Thia, K., Yuen, A., Rogers, B., Chachage, M., Moore, G., Shortt, J., Ryland, G., Blombery, P., Schwarer, A. P., Noori, T., Trapani, J. A., Jaworowski, A. & Voskoboinik, I., 8 Feb 2018, In : Blood. 131, 6, p. 699-702 4 p.

Research output: Contribution to journalLetterOtherpeer-review

2014
6 Citations (Scopus)

Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma

Campbell, P., Walker, P. A., Avery, S., Curtis, D. J., Schwarer, A., Wei, A., Kalff, A., Muirhead, J. L. & Spencer, A., 2014, In : Blood Cancer Journal. 4, 5, p. e213 - e213 3 p.

Research output: Contribution to journalLetterOther

2008
1 Citation (Scopus)

Urinary cytology in multiple myeloma

Patil, S., Schwarer, A. & McLean, C. A., 2008, In : Cytopathology. 19, 2, p. 130 - 131 2 p.

Research output: Contribution to journalLetterOther

2005

Correlation between disparity for the kappa immunoglobulin light chain and survival outcomes after allogeneic transplantation for B cell malignancies

Etto, T. L., Stewart, L. A., Muirhead, J. L. & Schwarer, A., 2005, In : Tissue Antigens. 66, 5, p. 407 - 408 2 p.

Research output: Contribution to journalLetterOther

Peripheral blood stem cell (PBSC) mobilization in patients with multiple myeloma: Low dose versus intermediate dose cyclophosphamide

Schwarer, A., McKendrick, J. & Bollard, G. M., 2005, In : Blood. 106, 11, p. 822A - 823A 2 p.

Research output: Contribution to journalLetterOther

1995
7 Citations (Scopus)

Clobazam for seizure prophylaxis during busulfan chemotherapy

Schwarer, A. P., Opat, S. S., Watson, A. L. & Cole-Sinclair, M. F., 4 Nov 1995, In : The Lancet. 346, 8984, 1 p.

Research output: Contribution to journalLetterOtherpeer-review